After repeated calls for action, the FDA has set a guideline for lead in baby food -- but it is not the end of the fight for ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

FDA Restructures its Food Resources Although there were a number of significant new regulations, the most significant food ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...

It is situated in the Gaddapotharam village of the Sanga Reddy district and owned and operated by Apitoria Pharma Pvt Ltd ...

In the wake of the 2024 U.S. elections, stakeholders in the life sciences and health care industry are intensely focused on the policy ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

Get Wall Street's Hottest Chart Every Morning After an inspection conducted between ... outlining its corrective measures and provide the FDA with a timeline for completion. Price Action: Sanofi ...

EBR Systems is girding for US FDA approval of its novel heart lead in April and commercialisation by the end of the year.

In another boost, the US Food and Drug Administration (FDA) has completed the manufacturing Pre-Approval Inspection (PAI ... that this is a likely timeline.” ...

CMS has accepted EBR's WiSE cardiac resynchronisation therapy (CRT) system into the fast-track TCET reimbursement pathway. ... Read More The post EBR’s US heart lead hopes tick up after wireless ...